Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue 2, 2010, Pages 145-150

  Yang, Huaiyu ^a   Chuzi, Sarah ^a   Sinicropi Yao, Lara ^a   Johnson, Dan ^a   Chen, Ying ^b   Clain, Alisabet ^a   Baer, Lee ^a   McGrath, Patrick J ^b   Stewart, Jonathan W ^b   Fava, Maurizio ^a   Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Depression; Relapse; Residual symptoms; SSRI; Unipolar

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PHOBIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RELAPSE; RISK ASSESSMENT; RISK FACTOR; SOMATIZATION; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; CHECKLIST; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PHOBIC DISORDERS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950864862     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-009-0031-3     Document Type: Article

References (16)

1. R Kessler P Berglund O Demler, et al. 2003 The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 23 3095 3105 10.1001/jama.289.23.3095 12813115 (Pubitemid 37432885)
2. M Trivedi A Rush S Wisniewski, et al. 2006 Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry 163 28 40 10.1176/appi.ajp.163.1.28 16390886 (Pubitemid 43050100)
3. J Geddes S Carney C Davies, et al. 2003 Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 9358 653 661 10.1016/S0140-6736(03)12599-8 1:CAS:528: DC%2BD3sXhsVajt7g%3D 12606176 (Pubitemid 36246547)
4. E Paykel R Ramana Z Cooper, et al. 1995 Residual symptoms after partial remission: an important outcome in depression Psychol Med 25 6 1171 1180 10.1017/S0033291700033146 1:STN:280:DyaK283ivFCqsw%3D%3D 8637947
5. N Kennedy E Paykel 2004 Residual symptoms at remission from depression: impact on long-term outcome J Affect Disord 80 135 144 10.1016/S0165-0327(03) 00054-5 1:STN:280:DC%2BD2czgsFKltw%3D%3D 15207926 (Pubitemid 38597136)
6. L Judd H Akiskal J Maser, et al. 1998 Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse J Affect Disord 50 97 108 10.1016/S0165-0327(98)00138-4 1:STN:280:DyaK1M%2FntlOrsg%3D%3D 9858069 (Pubitemid 28551779)
7. L Judd M Paulus P Schettler, et al. 2000 Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157 1501 1504 10.1176/appi.ajp.157.9.1501 1:STN:280: DC%2BD3cvktFCltA%3D%3D 10964869
8. L Judd P Schettler A Hagop, et al. 2008 Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence Arch Gen Psychiatry 65 4 386 394 10.1001/archpsyc.65.4.386 18391127 (Pubitemid 351519888)
9. A Rush M Trivedi S Wisniewski, et al. 2006 Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry 163 1905 1917 10.1176/appi.ajp.163.11.1905 17074942 (Pubitemid 44807782)
10. A Dombrovski B Mulsant P Houck, et al. 2007 Residual symptoms and recurrence during maintenance treatment of late life depression J Affect Disord 103 77 82 10.1016/j.jad.2007.01.020 17321595 (Pubitemid 47445755)
11. P McGrath J Stewart F Quitkin, et al. 2006 Predictors of relapse in a prospective study of fluoxetine treatment of major depression Am J Psychiatry 163 1542 1548 10.1176/appi.ajp.163.9.1542 16946178 (Pubitemid 44465753)
12. First M, Spitzer R, Gibbon M et al (1995) Structured clinical interview for DSM-IV axis I disorders-Patient Edition (SCID-I/P, Version 2.0). In: Biometrics Research Department, New York State Psychiatric Institute, New York
13. Guy W (1976) ECDEU Assessment manual for psychopharmacology, revised. In: National Institute of Mental Health, Rockville, MD
14. R Kellner 1987 A symptom questionnaire J Clin Psychiatry 48 268 274 1:STN:280:DyaL2s3ltVehsg%3D%3D 3597327 (Pubitemid 17108403)
15. L Derogatis R Lipman K Rickels, et al. 1974 The Hopkins symptom checklist (HSCL): a self-report symptom inventory J Appl Behav Sci 19 1 15 1:STN:280:DyaE2c%2FltlOquw%3D%3D (Pubitemid 9226316)
16. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 10.1136/jnnp.23.1.56 1:STN:280:DyaF3c7ltFyksw%3D%3D 14399272